A stroke may be preventable even when atrial fibrillation falls below the high-risk threshold, with blood-thinning drugs reducing serious complications without increasing major bleeding. The SINGLE-AF trial provides the first randomized evidence that direct oral anticoagulants (DOACs) can benefit people with atrial fibrillation and an intermediate risk of stroke. Over two years, these medications reduced [...]from SciTechDaily https://ift.tt/YvAW37T
